RaySearch receives RayStation order from University of North Carolina School of Medicine
RaySearch Laboratories AB (publ) announces that the University of North Carolina School of Medicine at Chapel Hill (UNC), USA, has purchased additional RayStation®* licenses to expand its already established use of the system. The expansion includes advanced proton planning capabilities in RayStation, such as LET optimization and proton arc therapy, supporting continued development of personalized cancer treatments. The order was received in the beginning of the third quarter of 2026.
UNC has been a RayStation customer since 2015, with the system now in use for photon planning across 12 sites. Building on this long-standing relationship, UNC is now expanding its use of RayStation to further enhance treatment precision and clinical flexibility through advanced proton planning capabilities.
The expansion is centered around a Mevion FIT® proton therapy system and includes plans to implement proton arc therapy, LET optimization and upright adaptive proton therapy. By combining advanced proton planning with adaptive workflows for upright treatment delivery, UNC aims to further personalize treatment strategies and explore new approaches to improving patient care and clinical efficiency.
“We have worked with RaySearch for many years and value the flexibility and advanced capabilities of RayStation,” says Dr. Shiva Das, Chief of Physics, University of North Carolina. “Expanding our use into advanced proton planning supports our ambition to further personalize treatments and improve clinical efficiency.”
“We are proud to have supported the network of clinics at the University of North Carolina for such a long time. Now that they move into proton therapy, RayStation supports their choice of treatment machine. This illustrates the power of RayStation’s support for a broad range of treatment machines, modalities, and treatment techniques,” says Johan Löf, founder and CEO of RaySearch. “We look forward to working with UNC in proton planning in general, as well as in the adoption of more advanced techniques such as LET optimization and proton arc therapy.”
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB
Tel: +46 (0) 8 510 530 00
Carolina Strömlid, Head of Investor Relations, RaySearch Laboratories AB
Tel: +46 (0) 708 807 173
ir@raysearchlabs.com
About the University of North Carolina School of Medicine
The University of North Carolina School of Medicine is a leading academic medical center located in Chapel Hill, North Carolina. Through the UNC Lineberger Comprehensive Cancer Center, it provides advanced cancer care to patients across North Carolina and the southeastern United States, while advancing research, education, and innovation in oncology.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure, and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch’s software has been sold to over 1,200 clinics in 51 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.
Learn more about us on:
LinkedIn
YouTube
* Subject to regulatory clearance in some markets.